| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lampropoulos Fred P. | Executive Chairman, Director | 1600 WEST MERIT PARKWAY, SOUTH JORDAN | /s/ Brian G. Lloyd, Attorney-in-Fact | 2025-11-20 | 0000901534 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Common Stock, No Par Value | Sale | -$424K | -5K | -0.46% | $84.83 | 1.07M | 18 Nov 2025 | Direct | F3 |
| holding | MMSI | Common Stock, No Par Value | 8.28K | 18 Nov 2025 | By spouse | F1 | |||||
| holding | MMSI | Common Stock, No Par Value | 98.1K | 18 Nov 2025 | By 401(k) Plan | F2 | |||||
| holding | MMSI | Common Stock, No Par Value | 90 | 18 Nov 2025 | By spouse as custodian for child | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MMSI | Non-qualified stock options (right to buy) | 100K | 18 Nov 2025 | Common Stock | 100K | $37.71 | Direct | F4 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 58.1K | 18 Nov 2025 | Common Stock | 58.1K | $56.25 | Direct | F5 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 54.3K | 18 Nov 2025 | Common Stock | 54.3K | $70.58 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| F2 | The 401(k) number represents plan holdings as of 10/31/2025. |
| F3 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.03 to $86.44, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F4 | Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. |
| F5 | Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. |
| F6 | Becomes exercisable in equal annual installments of 25% commencing 2/28/2024. |